A detailed history of Institute For Wealth Management, Llc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 12,942 shares of NVO stock, worth $1.13 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
12,942
Previous 12,931 0.09%
Holding current value
$1.13 Million
Previous $1.85 Million 16.48%
% of portfolio
0.2%
Previous 0.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $1,309 - $1,599
11 Added 0.09%
12,942 $1.54 Million
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $24,542 - $29,382
200 Added 1.57%
12,931 $1.85 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $6,432 - $8,562
63 Added 0.5%
12,731 $1.63 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $41,607 - $49,983
474 Added 3.89%
12,668 $1.31 Million
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $802,272 - $1.76 Million
8,822 Added 261.63%
12,194 $1.11 Million
Q4 2022

Feb 02, 2023

BUY
$102.55 - $135.33 $2,768 - $3,653
27 Added 0.81%
3,372 $456,000
Q1 2021

May 04, 2021

SELL
$67.06 - $75.82 $2,078 - $2,350
-31 Reduced 0.92%
3,345 $226,000
Q4 2020

Feb 01, 2021

SELL
$63.89 - $73.8 $6,964 - $8,044
-109 Reduced 3.13%
3,376 $236,000
Q2 2020

Jul 30, 2020

BUY
$58.54 - $67.94 $7,083 - $8,220
121 Added 3.6%
3,485 $228,000
Q1 2020

Apr 29, 2020

SELL
$49.46 - $64.78 $5,044 - $6,607
-102 Reduced 2.94%
3,364 $203,000
Q4 2019

Feb 27, 2020

BUY
$49.86 - $58.26 $162,792 - $190,218
3,265 Added 1624.38%
3,466 $201,000
Q4 2019

Jan 27, 2020

BUY
$49.86 - $58.26 $10,021 - $11,710
201 New
201 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Institute For Wealth Management, Llc. Portfolio

Follow Institute For Wealth Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.